EVALRIVE Trademark

Trademark Overview

On Friday, August 24, 2012, a trademark application was filed for EVALRIVE with the United States Patent and Trademark Office. The USPTO has given the EVALRIVE trademark a serial number of 85712123. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 8, 2016. This trademark is owned by GENENTECH, INC.. The EVALRIVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical oncology preparation, namely, pharmaceutical products for the prevention or treatment of cancer
evalrive

General Information

Serial Number85712123
Word MarkEVALRIVE
Filing DateFriday, August 24, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 8, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2012

Trademark Statements

Goods and ServicesPharmaceutical oncology preparation, namely, pharmaceutical products for the prevention or treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 4, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080
Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080

Trademark Events

Event DateEvent Description
Monday, February 8, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, February 8, 2016ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 16, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, July 15, 2015EXTENSION 5 GRANTED
Tuesday, July 7, 2015EXTENSION 5 FILED
Tuesday, July 7, 2015TEAS EXTENSION RECEIVED
Friday, January 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, January 8, 2015EXTENSION 4 GRANTED
Wednesday, January 7, 2015EXTENSION 4 FILED
Wednesday, January 7, 2015TEAS EXTENSION RECEIVED
Thursday, July 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Wednesday, July 9, 2014EXTENSION 3 GRANTED
Tuesday, July 8, 2014EXTENSION 3 FILED
Tuesday, July 8, 2014TEAS EXTENSION RECEIVED
Wednesday, February 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, February 4, 2014EXTENSION 2 GRANTED
Tuesday, December 17, 2013EXTENSION 2 FILED
Friday, January 31, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 17, 2013TEAS EXTENSION RECEIVED
Tuesday, July 9, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Friday, July 5, 2013EXTENSION 1 GRANTED
Friday, July 5, 2013EXTENSION 1 FILED
Friday, July 5, 2013TEAS EXTENSION RECEIVED
Tuesday, January 8, 2013NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 13, 2012PUBLISHED FOR OPPOSITION
Wednesday, October 24, 2012NOTICE OF PUBLICATION
Tuesday, October 2, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 27, 2012ASSIGNED TO EXAMINER
Tuesday, September 4, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 28, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

evalrive pharmaceutical treatment cancer prevention namely oncology preparation products